Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 851-152-7 | CAS number: 1374570-57-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 31 May - 02 August 2022
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 022
- Report date:
- 2022
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- N,N-dimethyldodec-9-enamide
- EC Number:
- 851-152-7
- Cas Number:
- 1374570-57-6
- Molecular formula:
- C14H27NO
- IUPAC Name:
- N,N-dimethyldodec-9-enamide
- Test material form:
- liquid
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA/Ca
- Remarks:
- CBA/CaCrl
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Charles River (UK) Ltd., Margate
- Females nulliparous and non-pregnant: yes
- Age at study initiation: approximately 9 to 10 weeks old on Day 1
- Weight at study initiation: Animals in the main studies were in a body weight range of 17 to 22 g on Day 1 of dosing. Individual body weights were within ±20% of the mean body weight for mice on the study.
- Housing: The animals were housed in groups of up to six during acclimatisation and housed in pairs from Day 1 in cages that conformed to the 'Code of Practice for the Housing and Care of Animals Bred, Supplied or Used for Scientific Purposes’ (Home Office, London, 2014).
Bedding was provided on a weekly basis to each cage by use of clean European softwood bedding (Datesand Ltd., Manchester, UK). The bedding had been analysed for specific contaminants and the results retained on file at Labcorp. No contaminants were present in bedding at levels which might have interfered with achieving the objective of the study.
- Diet (e.g. ad libitum): 5LF2 EU Rodent Diet 14%, was freely available to the animals at all times. Each batch of diet had been analysed for specific constituents and contaminants by the manufacturer. No contaminants were present in diet at levels which might have interfered with achieving the objective of the study.
- Water (e.g. ad libitum): Mains water was provided, ad libitum, via cage-mounted water bottles. The water had been periodically analysed for specific contaminants. No contaminants were present in water at levels which might have interfered with achieving the objective of the study.
- Acclimation period: 8 to 15 days
- Indication of any skin lesions: no
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19 to 25
- Humidity (%): 40 to 70
- Air changes (per hr): minimum of 15
- Photoperiod (hrs dark / hrs light): Fluorescent lighting was controlled automatically to give a cycle of 12 hours light and 12 hours dark.
- IN-LIFE DATES: From: To: 31 May - 02 August 2022
Study design: in vivo (LLNA)
- Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 100 %v/v; 50 % v/v; 25 %v/v; 10 %v/v; 5 %v/v; 2.5 %v/v
- No. of animals per dose:
- Preliminary screening test: 1 animal
Main study: 4 animals per dose - Details on study design:
- PRE-SCREEN TESTS:
- Compound solubility: The vehicle for the test article was 80% v/v acetone in olive oil, supplied by Labcorp. The vehicle was chosen because it was the first of the vehicles listed in the protocol that produced an overtly stable solution, emulsion or dispersion incorporating 50% v/v of the test article.
- Irritation: None observed
- Systemic toxicity: No death. Greasy fur to back of ears and neck observed on days 1, 3, 4, 5 & 6; Greasy fur to back, back of ears and neck observed on day 2
- Ear thickness measurements: See Table 9.5 below
- Erythema scores: 0 on days 1, 2, 3, 4, 5 & 6
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
Mice were arbitrarily selected from the delivery boxes and allocated to the appropriate number of cages. The condition of the animals was assessed daily throughout the acclimatisation period of 8 to 15 days. A second inspection was performed prior to study commencement to ensure the animals were suitable for the study. Overtly healthy animals were arbitrarily allocated to the study groups on the day of commencement of treatment.
- Criteria used to consider a positive response: The test article is regarded as a sensitiser when the maximum value of the SI is 3.0 or above. The test article is classified as a non-sensitiser when the maximum value of the SI is
less than 3.0. (This result is unchanged by observations of irritation at sites of application of the test formulation).
TREATMENT PREPARATION AND ADMINISTRATION:
Test Article Formulation
Formulations were freshly prepared as required using 80% v/v acetone in olive oil on Days 1, 2 and 3. The formulations were stored at room temperature, in sealed, air-tight containers prior to dosing and were used within two hours of preparation.
The formulations were mixed by multiple inversion of the containers prior to administration to ensure homogeneity.
Concentrations of test article were expressed volumetrically and in terms of test article received (without regard to purity or active content).
Test Article Administration
Each mouse was manually restrained with both auditory pinnae left free. The outer aspect of both pinnae of each mouse was treated by direct application of the appropriate vehicle control or test formulation (0.025 mL/pinna) dispensed from an automatic micro pipette.
Treatment Regimen
The groups of four female mice were subjected to application of the vehicle control or one of the test formulations to the outer aspect of the auditory pinnae, once daily on Days 1, 2 and 3. On Day 6 the mice were placed in a thermacage in order to dilate the peripheral blood vasculature and thus facilitate intravenous dosing. Each mouse was transferred to a cylindrical restrainer. A plastic syringe and fine gauge hypodermic needle were used to administer 0.25 mL phosphate buffered saline incorporating 20 μCi of 3HTdR into a tail vein of each mouse by slow bolus injection. After this treatment, the mice were returned to their cages. Approximately five hours after intravenous injection of the 3HTdR, all mice were killed by exanguination under a deep plane of inhalation anasthesia. Killing was organised to minimise the interval between death and the recovery of the auricular lymph nodes to no more than fifteen minutes.
Clinical Signs
Treated mice were observed twice daily on Days 1 to 5 and once on Day 6 for clinical signs of reaction to treatment or for irritation or other changes at the sites of application of the test article.
Routine Health Checks
All animals were examined at the beginning and end of the working day throughout the acclimatisation and study periods to ensure they were in good health.
Body Weights
Mice were weighed on Day 1 (the first day of dosing) and on Day 6 prior to intravenous administration of 3HTdR. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
Results and discussion
- Positive control results:
- See attached historical positive control data. These data confirm adequate performance of the assay.
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- EC3
- Value:
- 24.6
- Parameter:
- SI
- Value:
- 5.59
- Test group / Remarks:
- 100 %v/v
- Parameter:
- SI
- Value:
- 3.65
- Test group / Remarks:
- 50 %v/v
- Parameter:
- SI
- Value:
- 3.04
- Test group / Remarks:
- 25 %v/v
- Parameter:
- SI
- Value:
- 1.47
- Test group / Remarks:
- 10 %v/v
- Parameter:
- SI
- Value:
- 0.81
- Test group / Remarks:
- 5 %v/v
- Parameter:
- SI
- Value:
- 0.47
- Test group / Remarks:
- 2.5 %v/v
- Cellular proliferation data / Observations:
- DETAILS ON STIMULATION INDEX CALCULATION
Test results are expressed in terms of Stimulation Indices, the ratios of the mean scintillation counts obtained from the test groups relative to the corresponding mean scintillation count obtained from the vehicle control (see Table 9.1 & 9.2 below).
The threshold level for the Stimulation Index to be considered a positive indicator of the potential to cause skin sensitisation is 3.0.
EC3 CALCULATION
The EC3 value was calculated using the following equation:
EC3 = c+[(3-d)/(b-d)](a-c)
where
a = lowest concentration giving SI ≥ 3
b = actual SI caused by a
c = highest concentration failing to produce SI of 3
d = actual SI caused by c
The EC3 was calculated to be 24.6%.
CLINICAL OBSERVATIONS:
There were no clinical signs indicative of a systemic effect of treatment among mice treated with the vehicle or with 2.5%, 5%, 10%, 25%, 50% or 100% v/v formulations of the test article.
In the first main study, greasy wet fur on the back of the neck and ears was noted in all animals on Day 1. Greasy fur on the back of the neck and ears was noted in all animal from Days 2 to 4, persisting in animals in Groups 2, 3 and 4 on Days 5 and 6.
Incidents of greasy fur on the dorsal thoracic area and on the front legs were also noted on Days 4 and 5 in animals in Groups 3 and 4.
In the second main study, greasy fur on the back of the neck and ears was noted in all animals on Day 2, with greasy fur on the back of the neck and ears noted on Days 3 and 4 in animals treated at a concentration of 10% v/v.
BODY WEIGHTS
There was no indication of a treatment related effect on body weight (see Tables 9.6 & 9.7 below).
SIGNS OF TOXICITY (including dermal irritation at the site of administration, if any, e.g. increased ear thickness).
All animals survived treatment with N,N-dimethyldodec-9-enamide.
The vehicle and test formulation application sites remained free of irritation.
Any other information on results incl. tables
Table 9.1 Group DPMs and Stimulation Index (SI), Experiment 1
Concentration (% v/v in 80% v/v acetone in olive oil) |
Group Number |
Group DPM |
Stimulation Index (SI)a
|
Vehicle |
1 |
726 |
NA |
25 |
2 |
2207 |
3.04 |
50 |
3 |
2648 |
3.65 |
100 |
4 |
4060 |
5.59 |
a = Stimulation Index of 3.0 or greater indicates a positive result
NA = Not applicable
Table 9.2 Group DPMs and Stimulation Index (SI), Experiment 2
Concentration (% v/v in 80% v/v acetone in olive oil) |
Group Number |
Group DPM |
Stimulation Index (SI)a
|
Vehicle |
5 |
707 |
NA |
2.5 |
6 |
335 |
0.47 |
5 |
7 |
576 |
0.81 |
10 |
8 |
1040 |
1.47 |
a = Stimulation Index of 3.0 or greater indicates a positive result
NA = Not applicable
Table 9.5: Preliminary Screening Test - Ear Thickness Measurements
Concentration (% v/v) |
Animal Number |
Ear |
Thickness (mm) on Day: |
||
1 |
3 |
6 |
|||
100 |
257 |
Left |
0.21 |
0.21 |
0.21 |
Right |
0.20 |
0.21 |
0.22 |
Table 9.6 Body Weights, Main Experiment 1
Concentration (% v/v in 80% v/v acetone in olive oil) |
Group Number |
Animal Number |
Body Weights (g) |
|
Day 1 |
Day 6 |
|||
Vehicle |
1 |
258 |
20 |
21 |
259 |
19 |
20 |
||
260 |
19 |
20 |
||
261 |
22 |
22 |
||
25 |
2 |
262 |
19 |
20 |
263 |
20 |
22 |
||
264 |
22 |
24 |
||
265 |
21 |
20 |
||
50 |
3 |
266 |
20 |
21 |
267 |
20 |
20 |
||
268 |
20 |
21 |
||
269 |
20 |
21 |
||
100 |
4 |
270 |
20 |
19 |
271 |
22 |
19 |
||
272 |
20 |
20 |
||
273 |
22 |
19 |
Table 9.7 Body Weights, Main Experiment 2
Concentration (% v/v in 80% v/v acetone in olive oil) |
Group Number |
Animal Number |
Body Weights (g) |
|
Day 1 |
Day 6 |
|||
Vehicle |
5 |
318 |
19 |
20 |
319 |
19 |
21 |
||
320 |
17 |
18 |
||
321 |
18 |
20 |
||
2.5 |
6 |
322 |
19 |
19 |
323 |
17 |
21 |
||
324 |
20 |
22 |
||
325 |
17 |
18 |
||
5 |
7 |
326 |
19 |
21 |
327 |
19 |
20 |
||
328 |
17 |
19 |
||
329 |
19 |
21 |
||
10 |
8 |
330 |
17 |
19 |
331 |
19 |
21 |
||
332 |
17 |
19 |
||
333 |
19 |
21 |
Applicant's summary and conclusion
- Interpretation of results:
- Category 1B (indication of skin sensitising potential) based on GHS criteria
- Executive summary:
This study was conducted to assess the potential of the test article, N,N-dimethyldodec-9-enamide, to cause skin sensitisation in the mouse.
Following a preliminary screening test using the undiluted test article, the main study was conducted using the undiluted test article and 50 and 25% v/v formulations in 80% v/v acetone in olive oil. In order to calculate an EC3 value, a second experiment was conducted using 2.5%, 5% and 10% v/v formulations.
Groups of four female CBA/CaCrl mice were subjected to topical applications of vehicle control or of one of the test formulations to the outer aspect of the auditory pinnae once daily on Days 1, 2 and 3. On Day 6 a 20 μCi dose of tritiated 3H-methyl thymidine was injected intravenously into each mouse. Approximately five hours later the auricular lymph nodes were recovered from each animal. The pairs of nodes from each animal were pooled and suspensions of the cellular components of the lymph nodes were prepared in 5% w/v trichloroacetic acid and processed through a scintillation counter.
Test results are expressed in terms of Stimulation Indices, the ratios of the mean scintillation counts obtained from the test groups relative to the corresponding mean scintillation count obtained from controls. The threshold level for the Stimulation Index to be considered a positive indicator of the potential to cause skin sensitisation is 3.0.
Concentration of Test Article in Applied Formulation (% v/v)
2.5
5
10
25
50
100
Stimulation Index
0.47
0.81
1.47
3.04
3.65
5.59
The EC3 was calculated to be 24.6%.
The Local Lymph Node Assay demonstrated that N,N-dimethyldodec-9-enamide has the potential to cause skin sensitisation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)